We are live on !
Find out more
US Bancorp Portfolio holdings
AUM
$91.6B
Turnover
10.68%
1-Year Est. Return
29.2%
This Fund
S&P 500
This Quarter Est. Return
+17.62%
1 Year Est. Return
+29.2%
3 Year Est. Return
+76.81%
5 Year Est. Return
+86.62%
10 Year Est. Return
+295.59%
AUM
$91.6B
AUM Growth
+$9.19B
(+11%)
Cap. Flow
-$1.24B
Cap. Flow % of AUM
Cap. Flow %
-1.35%
Top 10 Holdings %
Top 10 Hldgs %
34.81%
Holding
4,393
New
231
Increased
1,584
Reduced
1,622
Closed
238
Avg Time Held
Equity + Options
7.2
years
Top 10 Avg Time Held
Equity + Options
6.5
years
Top 20 Avg Time Held
Equity + Options
5.3
years
Avg Time Held Equity only
7.2
years
Top 10 Avg Time Held Equity only
6.5
years
Top 20 Avg Time Held Equity only
5.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$775M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$555M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$178M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$92.1M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$88.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$1.04B |
| 2 |
Vanguard Total World Stock ETF
VT
|
+$550M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$484M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$376M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$304M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.23% |
| 2 | Technology | 15.14% |
| 3 | Financials | 7.27% |
| 4 | Healthcare | 5.74% |
| 5 | Industrials | 5.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3551
Dimensional International Small Cap ETF
DFIS
$5.73B
| $7.25K | ﹤0.01% |
207
-260
| -56% | -$9.31K |
2025 Q4
2 quarters
|
|
3552
Nu Skin
NUS
$228M
| $7.22K | ﹤0.01% |
1,368
-804
| -37% | -$5.14K |
2013 Q2
52 quarters
|
|
3553
United States Lime & Minerals
USLM
$3.15B
| $7.22K | ﹤0.01% |
69
-14
| -17% | -$1.62K |
2024 Q1
9 quarters
|
|
3554
Candel Therapeutics
CADL
$596M
| $7.2K | ﹤0.01% |
699
-32
| -4% | -$242 |
2026 Q1
1 quarter
|
|
3555
Arbutus Biopharma
ABUS
$832M
| $7.17K | ﹤0.01% |
1,494
-94
| -6% | -$413 |
2024 Q1
9 quarters
|
|
3556
ALPS O'Shares Global Internet Giants ETF
OGIG
$101M
| $7.17K | ﹤0.01% |
161
| – | – |
2025 Q2
4 quarters
|
|
3557
iShares S&P GSCI Commodity-Indexed Trust
GSG
$1.08B
| $7.15K | ﹤0.01% |
+250
| New | +$8K |
2026 Q2
0 quarters
|
|
3558
York Water
YORW
$517M
| $7.14K | ﹤0.01% |
233
-270
| -54% | -$8.11K |
2022 Q2
16 quarters
|
|
3559
Mission Produce
AVO
$1.03B
| $7.13K | ﹤0.01% |
605
+15
| +3% | +$190 |
2023 Q3
11 quarters
|
|
3560
Del Monte Corp
DMC
$1.37B
| $7.06K | ﹤0.01% |
253
-233
| -48% | -$8.19K |
2015 Q1
45 quarters
|
|
3561
Beta Bionics
BBNX
$1.11B
| $7.05K | ﹤0.01% |
450
+229
| +104% | +$2.72K |
2025 Q4
2 quarters
|
|
3562
Orchid Island Capital
ORC
$973M
| $7.03K | ﹤0.01% |
1,008
+891
| +762% | +$6.14K |
2024 Q4
6 quarters
|
|
3563
Fulgent Genetics
FLGT
$556M
| $7.02K | ﹤0.01% |
342
+258
| +307% | +$4.37K |
2020 Q4
22 quarters
|
|
3564
Andersons Inc
ANDE
$2.19B
| $6.98K | ﹤0.01% |
102
-174
| -63% | -$12.6K |
2023 Q4
10 quarters
|
|
3565
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
ETO
$493M
| $6.95K | ﹤0.01% |
225
| – | – |
2024 Q3
7 quarters
|
|
3566
United Parks & Resorts
PRKS
$1.39B
| $6.92K | ﹤0.01% |
145
+66
| +84% | +$2.56K |
2019 Q2
28 quarters
|
|
3567
Global X Autonomous & Electric Vehicles ETF
DRIV
$323M
| $6.83K | ﹤0.01% |
177
| – | – |
2025 Q2
4 quarters
|
|
3568
Byrna Technologies
BYRN
$112M
| $6.81K | ﹤0.01% |
1,015
| – | – |
2021 Q2
20 quarters
|
|
3569
DELISTED
Theravance Biopharma
TBPH
| $6.78K | ﹤0.01% |
399
+31
| +8% | +$513 |
2024 Q4
6 quarters
|
|
3570
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$508M
| $6.77K | ﹤0.01% |
1,102
| – | – |
2024 Q3
7 quarters
|
|
3571
Brightstar Lottery PLC
BRSL
$1.74B
| $6.76K | ﹤0.01% |
631
+31
| +5% | +$368 |
2022 Q3
15 quarters
|
|
3572
ODDITY Tech
ODD
$1.03B
| $6.64K | ﹤0.01% |
439
+349
| +388% | +$4.68K |
2025 Q2
4 quarters
|
|
3573
Olema Pharmaceuticals
OLMA
$579M
| $6.63K | ﹤0.01% |
530
+19
| +4% | +$255 |
2025 Q4
2 quarters
|
|
3574
USCF SummerHaven Dynamic Commodity Strategy No K-1 Fund
SDCI
$834M
| $6.61K | ﹤0.01% |
250
| – | – |
2026 Q1
1 quarter
|
|
3575
Gladstone Investment Corp
GAIN
$583M
| $6.59K | ﹤0.01% |
+426
| New | +$6.69K |
2026 Q2
0 quarters
|
|
Similar funds
US Bancorp's Q2 2026 Portfolio in Review
As of Q2 2026, US Bancorp held 4,393 positions worth $91.6B, up 11% from $82.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
US Bancorp's Q2 2026 filing shows 231 new, 1,584 increased, 1,622 reduced and 238 closed positions. Its largest new stake was Honeywell Aerospace: 400,519 shares worth $88.5M. The largest sale was iShares US Treasury Bond ETF, an estimated $1.04B.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 52% a quarter earlier, followed by Technology and Financials.
- US Bancorp's largest Q2 2026 buy was Honeywell Aerospace: 400,519 shares worth $88.5M.
- US Bancorp added most to Schwab US Large- Cap ETF in Q2 2026, an estimated $775M increase.
- US Bancorp's biggest Q2 2026 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.04B.
- US Bancorp fully exited Coterra Energy in Q2 2026, selling an estimated $68.5M.
- US Bancorp's ten largest holdings make up 35% of its $91.6B portfolio in Q2 2026.
- US Bancorp opened 231 new positions and closed 238 in Q2 2026.
- US Bancorp's portfolio value rose 11% quarter-over-quarter to $91.6B.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.